中国·太阳成集团tyc122cc(股份)有限公司-搜狗百科
Home
About Us
Company Profile
Milestones
CSR
Contact Us
Product Solutions
Structural Heart Solutions
Peripheral Vascular Solutions
Product Manuals
Research & Development
News
Company News
Investor Relations
Stock Information
Announcements & Financial Reports
Corporate Governance
IR Contacts
Join Us
中文
News
Company News
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
All
Please Select
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Search
LifeTech Scientific Corporation Announced 2024 Interim Results：International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8%
View Details
2024 / 08 / 30
LifeTech Scientific Corporation（1302.HK） Announces 2023 Interim Results
View Details
2023 / 08 / 30
LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022
View Details
2023 / 03 / 30
FDA-approved Investigator-initiated Pre-market Clinical Trial of LAmbre™ Plus LAA Closure System Obtained Medical Insurance Coverage in the US
View Details
2022 / 09 / 05
LifeTech Scientific Corporation（1302.HK）Announces 2022 Interim Results
View Details
2022 / 08 / 31
LifeTech Scientific Corporation（1302.HK） Announces 2021 Annual Results
View Details
2022 / 03 / 30
LifeTech and Medtronic Further Strategic Collaboration to Open New Chapter of Domestically-Made MRI-Conditional Pacemakers
View Details
2021 / 12 / 16
LifeTech Scientific Corporation Announces 2021 Interim Results
View Details
2021 / 08 / 30
LifeTech Scientific Corporation (1302.HK) Announced 2020 Annual Results
View Details
2021 / 03 / 30
LifeTech Scientific (1302.HK) Announced 2020 Interim Results
View Details
2020 / 08 / 28
1
2
·
